51 related articles for article (PubMed ID: 1692729)
1. Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation.
Kucera LS; Iyer N; Leake E; Raben A; Modest EJ; Daniel LW; Piantadosi C
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):491-501. PubMed ID: 1692729
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication.
Kucera LS; Leake E; Iyer N; Raben D; Myrvik QN
AIDS Res Hum Retroviruses; 1990 May; 6(5):641-7. PubMed ID: 1972888
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
Meyer KL; Marasco CJ; Morris-Natschke SL; Ishaq KS; Piantadosi C
J Med Chem; 1991 Apr; 34(4):1377-83. PubMed ID: 2016713
[TBL] [Abstract][Full Text] [Related]
5. The ratio of defective HIV-1 particles to replication-competent infectious virions.
Bourinbaiar AS
Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic cell inhibition with new ether lipid analogs.
Noseda A; Berens ME; Piantadosi C; Modest EJ
Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381
[TBL] [Abstract][Full Text] [Related]
7. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
Njai HF; Lewi PJ; Janssen CG; Garcia S; Fransen K; Kestens L; Vanham G; Janssen PA
Antivir Ther; 2005; 10(2):255-62. PubMed ID: 15865220
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
9. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.
Rozera C; Carattoli A; De Marco A; Amici C; Giorgi C; Santoro MG
J Clin Invest; 1996 Apr; 97(8):1795-803. PubMed ID: 8621762
[TBL] [Abstract][Full Text] [Related]
11. Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication.
Tang S; Poulin L; Levy JA
J Gen Virol; 1992 Apr; 73 ( Pt 4)():933-9. PubMed ID: 1634879
[TBL] [Abstract][Full Text] [Related]
12. Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro.
Baba M; Schols D; Nakashima H; Pauwels R; Parmentier G; Meijer DK; De Clercq E
J Acquir Immune Defic Syndr (1988); 1989; 2(3):264-71. PubMed ID: 2470892
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
Montaner LJ; Griffin P; Gordon S
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
[TBL] [Abstract][Full Text] [Related]
14. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
Barretina J; Blanco J; Armand-Ugón M; Gutiérrez A; Clotet B; Esté JA
Antivir Ther; 2003 Apr; 8(2):155-61. PubMed ID: 12741628
[TBL] [Abstract][Full Text] [Related]
16. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
[TBL] [Abstract][Full Text] [Related]
17. Analogs of 3'-amino-3'-deoxyadenosine inhibit HIV-1 replication.
Vander Heyden N; Rodi C; Ratner L
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):647-53. PubMed ID: 2611044
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
[TBL] [Abstract][Full Text] [Related]
19. Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor.
Filice G; Cereda PM; Orsolini P; Soldini L; Razzini E; Campisi D; Gulminetti R
Microbiologica; 1991 Apr; 14(2):77-93. PubMed ID: 1713289
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
Quan Y; Liang C; Brenner BG; Wainberg MA
J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
